Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1609452-30-3
2. Sel120
3. Sel-120
4. Se-120-34a
5. Sdm3m518pj
6. Sel120-34a (monohydrochloride)
7. 1609452-30-3 (hcl)
8. 7,8-dibromo-9-methyl-2-piperazin-1-yl-5,6-dihydro-4h-imidazo[4,5,1-ij]quinoline Hydrochloride
9. 4h-imidazo(4,5,1-ij)quinoline, 7,8-dibromo-5,6-dihydro-9-methyl-2-(1-piperazinyl)-, Hydrochloride (1:1)
10. 7,8-dibromo-5,6-dihydro-9-methyl-2-(1-piperazinyl)-4himidazo(4,5,1-ij)quinoline Hydrochloride
11. Unii-sdm3m518pj
12. Chembl4578881
13. Schembl17106021
14. S8840
15. Akos037648926
16. Ex-a2929-1
17. Hy-111388a
18. 7,8-dibromo-9-methyl-2-(piperazin-1-yl)-5,6-dihydro-4h-imidazo[4,5,1-ij]quinoline Hydrochloride
19. Bs-16042
20. Imidazo[4,5,1-ij]quinoline Hydrochloride
21. Cs-0041061
22. A17086
23. D80736
24. Sel120(sel120-34,sel120-34a)
25. 7,8-dibromo-9-methyl-2-piperazin-1-yl-5,6-dihydro-4h-
26. Sel120-34a Monohydrochloride (1609522-33-9 Free Base)
27. 6,7-dibromo-5-methyl-2-piperazin-1-yl-1,3-diazatricyclo[6.3.1.04,12]dodeca-2,4,6,8(12)-tetraene;hydrochloride
| Molecular Weight | 450.6 g/mol |
|---|---|
| Molecular Formula | C15H19Br2ClN4 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 1 |
| Exact Mass | 449.96445 g/mol |
| Monoisotopic Mass | 447.96650 g/mol |
| Topological Polar Surface Area | 33.1 Ų |
| Heavy Atom Count | 22 |
| Formal Charge | 0 |
| Complexity | 390 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A RVU120 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of RVU120, including repackagers and relabelers. The FDA regulates RVU120 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. RVU120 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A RVU120 supplier is an individual or a company that provides RVU120 active pharmaceutical ingredient (API) or RVU120 finished formulations upon request. The RVU120 suppliers may include RVU120 API manufacturers, exporters, distributors and traders.
RVU120 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of RVU120 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right RVU120 GMP manufacturer or RVU120 GMP API supplier for your needs.
A RVU120 CoA (Certificate of Analysis) is a formal document that attests to RVU120's compliance with RVU120 specifications and serves as a tool for batch-level quality control.
RVU120 CoA mostly includes findings from lab analyses of a specific batch. For each RVU120 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
RVU120 may be tested according to a variety of international standards, such as European Pharmacopoeia (RVU120 EP), RVU120 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (RVU120 USP).
LOOKING FOR A SUPPLIER?
